Antimicrobials
Fidaxomicin

Fidaxomicin

Restricted

None
Poor (Less than 20%)
See Additional Information

Spectrum of Activity

General Information

C. difficile infection

  • Assess for effectiveness of treatment

  • Assess for hypersensitivity

  • Nausea

  • Hypersensitivity

  • Fever

  • Absorption: Oral: Minimal systemic absorption

  • Distribution: Largely confined to the gastrointestinal tract

  • Metabolism: Intestinal hydrolysis to less active metabolite (OP-1118)

  • Excretion: Feces (>92% as unchanged drug and metabolites); urine (<1% as metabolite)

Approximately $3800-4200 per course (#20 tablets)